| 1 day | -1.13% |
| 3 years | 4.81 |  | 31.5 |
| 5 years | 4.81 | | 64.5 |
| 10 years | 4.81 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 67 | 21/05/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2020 | |
Jonathan Neely
IRC | Investor Relations Contact | - | 01/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Loh
BRD | Director/Board Member | 67 | 21/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/5/25 | Issuer sale | Chief Financial Officer | 82,491 | 0.8204% | ||
| 21/5/25 | Issuer sale | Director | 12,624 | 0.1255% | ||
| 21/5/25 | Issuer sale | Director | 12,624 | 0.1255% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -.--% | - | - | 97.22M | |
| +0.61% | +10.62% | +58.16% | +149.73% | 1,255B | |
| +3.81% | +2.82% | +48.35% | +82.58% | 641B | |
| +3.09% | +2.95% | +39.10% | +108.48% | 505B | |
| +1.25% | -0.78% | +52.56% | +66.87% | 381B | |
| +3.93% | +6.02% | +82.28% | +45.44% | 357B | |
| +2.10% | +4.26% | +34.93% | +61.10% | 303B | |
| +1.92% | +9.37% | +13.43% | +36.55% | 286B | |
| +3.73% | +6.82% | +61.48% | +77.31% | 249B | |
| +4.19% | +9.68% | +42.96% | +113.85% | 208B | |
| Average | +1.46% | +2.95% | +48.14% | +82.43% | 465.02B | |
| Weighted average by Cap. | +1.08% | +3.90% | +50.61% | +97.79% |
Employees
128
Sector
Pharmaceuticals
